SGLT2 Inhibitors Increase the Risk of Diabetic Ketoacidosis Developing in the Community and during Hospital Admission

Peter S. Hamblin, Rosemary Wong, Elif I. Ekinci, Spiros Fourlanos, Sonali Shah, Alicia R. Jones, Matthew J.L. Hare, Genevieve L. Calder, Dilan Seneviratne Epa, Elizabeth M. George, Rinky Giri, Mark A. Kotowicz, Mervyn Kyi, Nicole Lafontaine, Richard J. Macisaac, Brendan J. Nolan, David N. O'Neal, Debra Renouf, Suresh Varadarajan, Jennifer WongSylvia Xu, Leon A. Bach

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'SGLT2 Inhibitors Increase the Risk of Diabetic Ketoacidosis Developing in the Community and during Hospital Admission'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemistry